Healthcare News

REHOVOT, Israel and HOBOKEN, N.J., July 20, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for...

VERAXA has received Scientific Advice from the Paul-Ehrlich-Institute providing an initial derisking of the development path of its BiTAC-TCE program.

New York City, New York, USA, July 20, 2026 (GLOBE NEWSWIRE) -- The 2026 launch positions ColestZen as a cholesterol-focused formula aimed at being a steady partner in managing...

STAFFORD, Texas, July 20, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...

REDWOOD CITY, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the Special Committee...

Cytosurge elects biotech leader Luba Greenwood to its Board, scaling its Same-Cell Biology platform to solve the causal data bottleneck in AI drug discover

MELBOURNE, Australia and NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced that its American Depositary Share (ADS) is expected to commence trading on the...

Fangzhou announced the launch of Kyinsu®, the world's first once-weekly basal insulin/GLP-1 RA combination therapy, on its Internet hospital platform.

After a single intravitreal dose of 4D-150, visual acuity and anatomic control was maintained with consistent and durable treatment burden reduction through 2 years 4D-150 continues to be well...

挪威奥斯陆, July 18, 2026 (GLOBE NEWSWIRE) -- 医疗决策学会 (Society for Medical Decision Making, SMDM) 将其最高职业荣誉 2026 年度职业成就奖授予 UMIT TIROL 及哈佛大学教授 Uwe...